AirGo
AirGo (MyAir, Inc.) is a Boston and Milan-based medtech company that has built a CE Class IIa certified wireless respiratory monitoring platform — combining a 75g wearable recorder, a mobile app, and an AI Semantic Engine — to deliver 24/7 breath-by-breath monitoring and automated sleep disorder screening for hospitals, sleep clinics, and ICUs.
- Company typePrivate
- Founded2015
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What AirGo does
AirGo (legally MyAir, Inc.) is a privately held medical technology company headquartered in Boston with Italian operations in Milan (MyAirgo Italy Srl) that has built a 24/7 non-invasive wireless respiratory monitoring platform. The platform consists of three integrated components: the Airgo Recorder, a patented CE Class IIa certified wearable device worn around the floating ribs weighing 75 grams and capturing 6+ weeks of continuous breath-by-breath data; the Airgo app, an iOS/Android application that transfers data via Bluetooth for live and recorded monitoring sessions; and the Airgo Semantic Engine, an AI-powered analytics layer using edge computing and proprietary algorithms — including Respiratory Instability Curves (RIC) that correlate to AHI values — to deliver automated scoring, live alerts, predictive analytics, and AI-aided diagnostic reports. Validated clinical performance includes 94% positive predictive value, 89% negative predictive value, and 97.5% sensitivity for OSA detection, supported by 50,000+ hours of monitoring data across 1,100+ patients at institutions including Massachusetts General Hospital, Fondazione Maugeri, and the Minnesota Sleep Institute.
AirGo targets clinical use cases across sleep disorder screening, ICU continuous respiratory monitoring, post-operative care, remote patient monitoring, and rehabilitation. The company operates a sales-led go-to-market model through direct hospital enterprise sales, supplemented by clinical partnership-driven distribution via research collaborations. Revenue mechanics span hardware sales of the Recorder device, recurring software/analytics subscriptions for the Semantic Engine, and clinical trial services. Pricing is quote-based and not publicly disclosed, reflecting an enterprise procurement motion. The company has raised approximately €2 million in total Series A funding from HTH – Health Technology Holding and Istituti Clinici Scientifici Maugeri, and has executed strategic partnerships with Vodafone (5G telemonitoring) and Politecnico di Milano, alongside academic and clinical collaborations in both North America and Europe.
The operating footprint is geographically narrow (USA and Italy only), headcount is reported at 1–10 employees, and the company remains privately held with no IPO or acquisition activity disclosed. The latest dated milestones include CE Medical Device Class IIa certification in 2020, Covid-19 ICU deployments across four hospitals, and the 2023 publication of deep neural network sleep staging research with MGH, indicating a company that has built strong clinical and regulatory foundations but has not yet publicly demonstrated material commercial scale.
AirGo firmographics
Firmographics- Name
- AirGo
- Legal name
- MyAir, Inc.
- Website
- https://myairgo.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- AirGo (MyAir, Inc.) is a Boston and Milan-based medtech company that has built a CE Class IIa certified wireless respiratory monitoring platform — combining a 75g wearable recorder, a mobile app, and an AI Semantic Engine — to deliver 24/7 breath-by-breath monitoring and automated sleep disorder screening for hospitals, sleep clinics, and ICUs.
- Ownership category
- akta.pro rank
AirGo industry classification
Industry- Product category
- Wireless Respiratory Monitoring Medical Devices
- akta.pro primary industry
- Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)
- akta.pro secondary industries
- Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Respiratory & Sleep RPM (COPD, asthma, sleep apnea) (HLALAFAB), Pulmonary Function Testing (PFT) & Respiratory Diagnostics (HLAKANAC)
Keywords
Where AirGo is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
AirGo business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others
Revenue model
- Medical Device Sales: Sale of Airgo Recorder hardware device - CE Class IIa certified hospital-grade respiratory recorder sold to healthcare institutions including hospitals, sleep clinics, and rehabilitation centers.
- Software Analytics Platform: Airgo Semantic Engine software providing AI-powered respiratory analytics, automated scoring, predictive alerts, and diagnostic reports. Sold as part of the platform or as ongoing service.
- Clinical Trial Services: Research collaboration and clinical trial services conducted with hospital partners for validation studies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Annual | Enterprise/hospital pricing for Airgo platform |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
AirGo product offering
Product offeringCore offering
AirGo provides a 24/7 non-invasive wireless respiratory monitoring platform comprising a CE Class IIa certified 75-gram wearable recorder (Airgo Recorder), a Bluetooth companion mobile app (Airgo app), and an AI-powered analytics platform (Airgo Semantic Engine) that captures continuous breath-by-breath data, automates sleep-disorder scoring, and delivers predictive alerts for use by hospitals, sleep clinics, ICUs, and rehabilitation centers.
Product overview
AirGo offers a unified 24/7 non-invasive wireless respiratory monitoring platform comprising three integrated products: the Airgo Recorder (a CE Class IIa certified wearable device worn on the chest that captures breath-by-breath biometric data), the Airgo app (iOS/Android mobile application enabling Bluetooth data transfer and session management), and the Airgo Semantic Engine (AI/ML analytics platform that processes raw respiratory data into automated scoring, predictive alerts, and diagnostic reports). The platform is designed for clinical use in sleep disorder screening, hospital monitoring, and remote patient care.
Differentiator
Problem solved
Functional benefit
Products and services
- Airgo Recorder A patented, CE Class IIa certified hospital-grade wearable medical device worn around the floating ribs. Weighs 75 grams, captures 6+ weeks of continuous data with 3 weeks battery autonomy. Measures Respiratory Rate (RR), Relative Tidal Volume (Vt), Relative Minute Ventilation (Mv), Inhalation/Exhalation Time (Ti/Te), Functional Residual Capacity (FRC), Posture and Activity, Sleep Staging, and periodic breathing patterns (Cheyne-Stokes, Kussmaul, Apnea). Sold to hospitals, sleep disorder clinics, and rehabilitation centers.
- Airgo app Companion mobile application for iOS and Android that communicates via Bluetooth (BLE) with the Airgo Recorder. Transfers biometric data for live and recorded monitoring sessions of patients in daily activity, hospital, and home settings.
- Airgo Semantic Engine AI-powered analytics platform using edge computing and proprietary algorithms that processes biometric data to provide respiratory trend analytics, live alerts, AI-aided diagnostic reports, and proprietary Respiratory Instability Curves (RIC) that correlate to industry-standard AHI values. Includes automated sleep disorder detection (OSA, CSA, Cheyne-Stokes, AHI/RDI scoring) and deep neural network ICU sleep staging (co-developed with Massachusetts General Hospital). Sold as part of the platform with recurring subscription.
Quantifiable outcome
- 94% positive predictive value and 89% negative predictive value for obstructive sleep apnea (OSA) detection
- +5 more outcomes
Companies that use AirGo
Customer profileNamed customers7 records
Segments7 records
Ideal customer profiles1 record
AirGo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
AirGo partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, major and minor.
- Massachusetts General Hospital (MGH)coreClinical research partnership for sleep staging in ICU using deep neural networks. MGH conducted sleep scoring validation vs PSG Gold standard (400+ patients, 2018). High prevalence of sleep disordered breathing study published in Sleep and Breathing journal.
- Fondazione Maugeri IRCCS VerunocoreClinical research partnership for sleep monitoring validation (150+ patients, 2019). Device clinically tested at Maugeri for World Sleep Day screening programs. Ongoing collaboration for Covid-19 monitoring and respiratory disorder studies.
- Minnesota Sleep InstitutecoreClinical validation partnership for sleep scoring vs PSG Gold standard (60+ patients, 2015). Early partner in clinical validation of Airgo platform.
- Ospedale Santa Croce e Carle CuneocoreClinical validation partnership for spirometry monitoring (21 patients) and comparison with metabolic cart. Validation study published in Sensors journal (2020) showing Airgo precision at rest and exercise.
- Ospedale San Raffaele (Milan)majorClinical research partnership for respiratory monitoring studies in Milan, Italy.
- Politecnico di MilanocoreAcademic research partnership for wearable respiratory monitoring technology development. Published comparison of Airgo and metabolic cart signals. Collaborated on 5G telemonitoring system with Vodafone.
- Vodafonemajor5G telemonitoring trial partnership for home telemedicine system for continuous respiratory monitoring. Vodafone 5G infrastructure incorporated into Airgo platform for home patient monitoring.
- Elite Athletic CoachesminorCollaborations with elite athletic coaches where strategic breathing is key to performance. These collaborations contribute to understanding of respiratory dynamics across the full spectrum.
- AIPO (Associazione Italiana Pneumologi Ospedalieri)majorItalian Association of Hospital Pneumologists - conducted webinar on March 25, 2021 titled 'Cattura il respiro / Catch your breath' featuring Airgo device and diagnostic paths for sleep disorder screening.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
AirGo competitors and assessment
Company assessmentDirect peers
- Nox Medical: Nox Medical develops wearable sleep diagnostic and respiratory monitoring devices (Noxturnal, T3 device), directly comparable to Airgo's wireless respiratory recorder and software analytics stack for sleep labs and home sleep testing.
- SOMNOmedics: SOMNOmedics manufactures portable polysomnography and respiratory monitoring systems (SOMNOwatch, SOMNOscreen) used in sleep medicine and cardiology — a direct competitor in clinical-grade wireless respiratory and sleep monitoring.
- Compumedics: Compumedics supplies sleep diagnostics, EEG, and respiratory monitoring hardware (Siesta, Grael) to sleep labs and hospitals worldwide, comparable to Airgo's clinical sleep screening and respiratory monitoring offering.
- Itamar Medical (WatchPAT): Itamar Medical's WatchPAT is a wearable home sleep apnea test using peripheral arterial tone signals — a direct competitor in the simplified, ambulatory OSA diagnostic category that Airgo also targets.
- Cidelec: Cidelec designs ambulatory sleep apnea screening and respiratory monitoring devices (CID-LXe, Pneumotel) used by sleep centers and occupational health providers — a direct competitor in the wireless OSA screening and respiratory monitoring category.
- COSMED: COSMED manufactures cardiopulmonary and metabolic diagnostic equipment including wearable indirect calorimetry and spirometry (K5, Quark), comparable to Airgo's respiratory monitoring and pulmonary function validation work.
Broad incumbents
- ResMed: ResMed is the global leader in sleep apnea therapy and connected respiratory care, with a broad portfolio spanning CPAP devices, masks, and digital health — an incumbent whose sleep diagnostics and connected-health efforts compete broadly with Airgo's screening and RPM platform.
- Philips Respironics: Philips Respironics is a major incumbent in sleep apnea diagnosis and therapy, with Alice PSG systems and a broad hospital respiratory monitoring portfolio — a broad incumbent competing with Airgo across sleep labs and hospital respiratory monitoring.
- Vyaire Medical: Vyaire Medical is a broad incumbent in respiratory diagnostics and ventilation, with spirometry and pulmonary function products overlapping with Airgo's clinical respiratory monitoring and pulmonary assessment capabilities.
Emerging players
- Spire Health: Spire Health produces a wearable respiratory monitoring patch for continuous lung function tracking, comparable to Airgo's wireless respiratory recorder — overlapping in home-based continuous respiratory monitoring use cases.
Market position
Strengths1 record
Weaknesses1 record
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
AirGo social profiles
Digital presenceAirGo compliance and trust
Trust signalCompliance2 records
AirGo financial estimates
Financial estimateRevenue estimate
Valuation estimate
AirGo leadership team
Management profileNumber of profiles
Profiles1 record
AirGo subsidiaries and ownership
Company hierarchySubsidiaries1 record
AirGo funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AirGo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AirGo
What does AirGo do?
AirGo provides a 24/7 non-invasive wireless respiratory monitoring platform comprising a CE Class IIa certified 75-gram wearable recorder (Airgo Recorder), a Bluetooth companion mobile app (Airgo app), and an AI-powered analytics platform (Airgo Semantic Engine) that captures continuous breath-by-breath data, automates sleep-disorder scoring, and delivers predictive alerts for use by hospitals, sleep clinics, ICUs, and rehabilitation centers.
Is AirGo a public or private company?
AirGo is a private company. It is classified as venture growth investor backed and is currently operating.
When was AirGo founded?
AirGo was founded in 2015. It employs 1 to 10 people.
Where is AirGo based?
AirGo is headquartered in Boston, United States, in the North America region.
How does AirGo make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are software Analytics Platform and clinical Trial Services.
Who are AirGo's main competitors?
Direct peers on record are Nox Medical, SOMNOmedics, Compumedics, Itamar Medical (WatchPAT), Cidelec and COSMED. Broad incumbents are ResMed, Philips Respironics and Vyaire Medical. Spire Health is listed as an emerging player.
Does AirGo have an API?
No public API is recorded for AirGo.
What industry is AirGo in?
AirGo's product category is Wireless Respiratory Monitoring Medical Devices. Its primary akta.pro industry code is HLAHAGAI, Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate), with a secondary code of HLAHACAD, Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry).